The emerging therapy of this peptide represents a major development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – https://tirzepatidepeptide928301.answerblogs.com/42397766/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment